Founded 2007 by Jan Mikael Nordfors MD, only for informational purposes. Shall not replace the advice of a skilled therapist.
You are here
Items per page
Phase II Study of Dasatinib in Patients with Metastatic Castration-Resistant Prostate Cancer.
Dasatinib inhibits the growth of prostate cancer in bone and provides additional protection from osteolysis.
Action of the Src family kinase inhibitor, dasatinib (BMS-354825), on human prostate cancer cells.
The Mikael Nordfors site operates under a Creative Commons License
Copyright © 2020,